SCHEMBL2807529

SCHEMBL2807529

CC(=COc1ccccc1)C(=O)Nc1cccc(C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.54
HSD17B10 Q99714 1/20 0.53
MAOB P27338 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MAOA P21397 2/20 0.49
EGFR P00533 1/20 0.49
MMP1 P03956 1/20 0.49
MMP2 P08253 1/20 0.49
MMP9 P14780 1/20 0.49
FAAH O00519 1/20 0.49
CYP3A4 P08684 1/20 0.49
KMT2A Q03164 5/20 0.48
MEN1 O00255 4/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
LMNA P02545 2/20 0.47
TP53 P04637 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807524 1.00 MAPK1 (0.54) MAPK1HSD17B10MAOBALDH1A1MAOA
SCHEMBL2811164 0.92 HTT (0.50) MAPK1HSD17B10MAOBALDH1A1MAOA
SCHEMBL2811168 0.92 HTT (0.50) MAPK1HSD17B10MAOBALDH1A1MAOA
SCHEMBL2811479 0.87 NAPRT (0.48) MAPK1HSD17B10ALDH1A1CYP3A4KMT2A
SCHEMBL2811474 0.87 NAPRT (0.48) MAPK1HSD17B10ALDH1A1CYP3A4KMT2A
SCHEMBL2808784 0.86 LMNA (0.45) MAPK1HSD17B10ALDH1A1FAAHCYP3A4
SCHEMBL2808788 0.86 LMNA (0.45) MAPK1HSD17B10ALDH1A1FAAHCYP3A4
SCHEMBL2808892 0.85 MEN1 (0.54) ALDH1A1MMP1MMP2MMP9FAAH
SCHEMBL2808897 0.85 MEN1 (0.54) ALDH1A1MMP1MMP2MMP9FAAH
SCHEMBL2811497 0.85 KMT2A (0.47) HSD17B10ALDH1A1EGFRMMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 MAPK1 2698/4885HSD17B10 1243/4885MAOB 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.